Olomorasib Clinical Trials
4 recruitingDrug
Phase 13Phase 31Phase 21
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer
Janssen Research & Development, LLC60 enrolled15 locationsNCT07227025
Recruiting
Phase 3
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Eli Lilly and Company700 enrolled354 locationsNCT06890598
Recruiting
Phase 1
A Study of Olomorasib (LY3537982) in Healthy Participants
Healthy
Eli Lilly and Company15 enrolled1 locationNCT07439250
Recruiting
Phase 1
A Study of Multiple Olomorasib (LY3537982) Capsules in Healthy Participants
Healthy
Eli Lilly and Company120 enrolled2 locationsNCT07044271